Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
13.51
-0.35 (-2.53%)
At close: May 15, 2026, 4:00 PM EDT
13.50
-0.01 (-0.07%)
After-hours: May 15, 2026, 4:36 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $540.4 million as of May 15, 2026. Its market cap has increased by 632.25% in one year.
Market Cap
540.40M
Enterprise Value
557.82M
1-Year Change
632.25%
Ranking
Category
Stock Price
$13.51
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $540.40M, a decrease of -2.37%. That is a compound annual growth rate of -0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 540.40M | 931.34% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 588.61M |
| Altimmune | 567.86M |
| Valneva SE | 567.81M |
| Prime Medicine | 565.33M |
| Tectonic Therapeutic | 562.30M |
| AgomAb Therapeutics NV | 543.70M |
| Climb Bio | 541.22M |
| Immix Biopharma | 535.42M |